Bio-Techne Corp (TECH)

Net profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net income	US$ in thousands	73,400	168,105	285,263	272,051	140,410
Revenue	US$ in thousands	1,219,640	1,159,060	1,136,700	1,105,600	931,032
Net profit margin		6.02%	14.50%	25.10%	24.61%	15.08%

June 30, 2025 calculation

Net profit margin = Net income ÷ Revenue
= $73,400K ÷ $1,219,640K
= 6.02%

The net profit margin of Bio-Techne Corp has exhibited notable fluctuations over the specified period. On June 30, 2021, the company reported a net profit margin of 15.08%, indicating a moderate level of profitability relative to its revenue. This margin experienced a significant increase by June 30, 2022, reaching 24.61%, nearly doubling the previous year's figure, which suggests improved operational efficiency, higher profit generation, or favorable market conditions during that period. The upward trend continued into June 30, 2023, with the net profit margin slightly increasing to 25.10%, reflecting sustained profitability improvements or continued favorable factors.

However, the margin declined sharply in the subsequent year, falling to 14.50% by June 30, 2024. This decline indicates a reduction in profitability relative to revenue, which could be attributed to increased costs, reduced pricing power, or other operational challenges. The downward trend persisted into June 30, 2025, with the net profit margin decreasing further to 6.02%, representing a significant compression of profitability and possibly signaling financial strain or substantial increases in expenses.

Overall, the net profit margin displays a pattern characterized by a substantial enhancement from 2021 to 2023, followed by a pronounced decline in 2024 and 2025. This trajectory underscores periods of both robust profit realization and notable margin compression, warranting ongoing monitoring of the company's cost management, revenue contributions, and overall operational health.